Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (13)
Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus
1992 • 2,028 citations
Estimates of the worldwide frequency of sixteen major cancers in 1980
1988 • 1,073 citations
Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients
1995 • 1,031 citations
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer
1995 • 796 citations
Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer
1993 • 787 citations
Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.
1993 • 560 citations
Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites
1990 • 400 citations
Endosonography and computed tomography of esophageal carcinoma
1989 • 328 citations
Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.
1989 • 304 citations
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)
1994 • 262 citations
Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction.
1990 • 105 citations
Chemotherapy of carcinoma of the stomach
1993 • 55 citations
The natural history and results of surgical therapy for carcinoma of the stomach
1961 • 39 citations
Cited By (0)
No citing papers found in database